BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 24046525)

  • 21. The clinical characteristics of autoimmune haemolytic anaemia/Evans syndrome patients with clonal immunoglobulin/T cell receptor gene rearrangement.
    Zhu H; Zhao M; Cao Z; Yang J; Li Y; Xing L
    Autoimmunity; 2020 Nov; 53(7):394-399. PubMed ID: 32924630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of antigen receptor gene rearrangement of BIOMED-2 in the pathologic diagnosis of 348 cases with non-Hodgkin lymphoma in a single institution in Southwest of China.
    Liu X; He H; Li Y; Huang Y; Li G; Yu Q; Li W; Li D
    Pathol Res Pract; 2019 Nov; 215(11):152615. PubMed ID: 31562020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience.
    Mannu C; Gazzola A; Bacci F; Sabattini E; Sagramoso C; Roncolato F; Rossi M; Laginestra MA; Sapienza MR; Agostinelli C; De Leo A; Piccioli M; Righi S; Artioli P; Chilli L; Da Pozzo G; De Biase G; Sandri F; Pileri SA; Piccaluga PP
    Am J Blood Res; 2011; 1(2):167-74. PubMed ID: 22432078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pitfalls in TCR gene clonality testing: teaching cases.
    Groenen PJ; Langerak AW; van Dongen JJ; van Krieken JH
    J Hematop; 2008 Sep; 1(2):97-109. PubMed ID: 19669208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of clonal immunoglobulin and T-cell receptor gene recombination in hematological malignancies: monitoring minimal residual disease.
    García-Castillo H; Barros-Núñez P
    Cardiovasc Hematol Disord Drug Targets; 2009 Jun; 9(2):124-35. PubMed ID: 19519371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of immunoglobulin heavy chain gene rearrangements in classic hodgkin lymphoma using commercially available BIOMED-2 primers.
    Chute DJ; Cousar JB; Mahadevan MS; Siegrist KA; Silverman LM; Stoler MH
    Diagn Mol Pathol; 2008 Jun; 17(2):65-72. PubMed ID: 18382369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B- and T-cell clonality in diagnostic haematopathology.
    Liu H; Bench AJ; Bacon CM; Payne K; Huang Y; Scott MA; Erber WN; Grant JW; Du MQ
    Br J Haematol; 2007 Jul; 138(1):31-43. PubMed ID: 17555445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revised response criteria for malignant lymphoma.
    Cheson BD; Pfistner B; Juweid ME; Gascoyne RD; Specht L; Horning SJ; Coiffier B; Fisher RI; Hagenbeek A; Zucca E; Rosen ST; Stroobants S; Lister TA; Hoppe RT; Dreyling M; Tobinai K; Vose JM; Connors JM; Federico M; Diehl V;
    J Clin Oncol; 2007 Feb; 25(5):579-86. PubMed ID: 17242396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
    Evans PA; Pott Ch; Groenen PJ; Salles G; Davi F; Berger F; Garcia JF; van Krieken JH; Pals S; Kluin P; Schuuring E; Spaargaren M; Boone E; González D; Martinez B; Villuendas R; Gameiro P; Diss TC; Mills K; Morgan GJ; Carter GI; Milner BJ; Pearson D; Hummel M; Jung W; Ott M; Canioni D; Beldjord K; Bastard C; Delfau-Larue MH; van Dongen JJ; Molina TJ; Cabeçadas J
    Leukemia; 2007 Feb; 21(2):207-14. PubMed ID: 17170731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.
    Brüggemann M; White H; Gaulard P; Garcia-Sanz R; Gameiro P; Oeschger S; Jasani B; Ott M; Delsol G; Orfao A; Tiemann M; Herbst H; Langerak AW; Spaargaren M; Moreau E; Groenen PJ; Sambade C; Foroni L; Carter GI; Hummel M; Bastard C; Davi F; Delfau-Larue MH; Kneba M; van Dongen JJ; Beldjord K; Molina TJ
    Leukemia; 2007 Feb; 21(2):215-21. PubMed ID: 17170730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
    Langerak AW; Molina TJ; Lavender FL; Pearson D; Flohr T; Sambade C; Schuuring E; Al Saati T; van Dongen JJ; van Krieken JH
    Leukemia; 2007 Feb; 21(2):222-9. PubMed ID: 17170729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of BIOMED-2 primers in fixed and decalcified bone marrow biopsies: analysis of immunoglobulin H receptor rearrangements in B-cell non-Hodgkin's lymphomas.
    Lassmann S; Gerlach UV; Technau-Ihling K; Werner M; Fisch P
    J Mol Diagn; 2005 Nov; 7(5):582-91. PubMed ID: 16258156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics.
    Sandberg Y; van Gastel-Mol EJ; Verhaaf B; Lam KH; van Dongen JJ; Langerak AW
    J Mol Diagn; 2005 Oct; 7(4):495-503. PubMed ID: 16237219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL).
    Mitterbauer-Hohendanner G; Mannhalter C; Winkler K; Mitterbauer M; Skrabs C; Chott A; Simonitsch-Klupp I; Gleiss A; Lechner K; Jaeger U
    Leukemia; 2004 Jun; 18(6):1102-7. PubMed ID: 15085149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
    van Dongen JJ; Langerak AW; Brüggemann M; Evans PA; Hummel M; Lavender FL; Delabesse E; Davi F; Schuuring E; García-Sanz R; van Krieken JH; Droese J; González D; Bastard C; White HE; Spaargaren M; González M; Parreira A; Smith JL; Morgan GJ; Kneba M; Macintyre EA
    Leukemia; 2003 Dec; 17(12):2257-317. PubMed ID: 14671650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of IgH-PCR to the evaluation of B-cell lymphoma involvement in paraffin-embedded bone marrow biopsy specimens.
    Braunschweig R; Baur AS; Delacrétaz F; Bricod C; Benhattar J
    Am J Clin Pathol; 2003 May; 119(5):634-42. PubMed ID: 12760281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders.
    Sah SP; Matutes E; Wotherspoon AC; Morilla R; Catovsky D
    J Clin Pathol; 2003 Feb; 56(2):129-32. PubMed ID: 12560392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of lymphoma classification in bone marrow trephines.
    Buhr T; Länger F; Schlué J; von Wasielewski R; Lehmann U; Braumann D; Kreipe H
    Br J Haematol; 2002 Aug; 118(2):470-6. PubMed ID: 12139734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudo-spikes are common in histologically benign lymphoid tissues.
    Lee SC; Berg KD; Racke FK; Griffin CA; Eshleman JR
    J Mol Diagn; 2000 Aug; 2(3):145-52. PubMed ID: 11229519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactive and neoplastic lymphocytes in human bone marrow: morphological, immunohistological, and molecular biological investigations on biopsy specimens.
    Kröber SM; Horny HP; Greschniok A; Kaiserling E
    J Clin Pathol; 1999 Jul; 52(7):521-6. PubMed ID: 10605406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.